Avadel Pharmaceuticals-adr logo

Avadel Pharmaceuticals-adr Share Price Today

(NASDAQ: AVDL)

Avadel Pharmaceuticals-adr share price is $7.85 & ₹676.59 as on 25 Jan 2025, 2.30 'hrs' IST

$7.85

-0.09

(-1.13%)

Market is closed - opens 8 PM, 27 Jan 2025

View live Avadel Pharmaceuticals-adr share price in Dollar and Rupees. Guide to invest in Avadel Pharmaceuticals-adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Avadel Pharmaceuticals-adr, along with analyst recommendations, forecasts, and comprehensive financials.

Avadel Pharmaceuticals-adr share price movements

  • Today's Low: $7.77
    Today's High: $7.98

    Day's Volatility :2.63%

  • 52 Weeks Low: $7.39
    52 Weeks High: $19.09

    52 Weeks Volatility :61.29%

Avadel Pharmaceuticals-adr Returns

PeriodAvadel Pharmaceuticals-adrSector (Health Care)Index (Russel 2000)
3 Months
-38.67%
-2.9%
0.0%
6 Months
-51.9%
-3.2%
0.0%
1 Year
-43.24%
4.2%
0.0%
3 Years
38.45%
12.6%
-11.7%

Avadel Pharmaceuticals-adr Key Statistics

in dollars & INR

Previous Close
$7.94
Open
$7.9
Today's High
$7.98
Today's Low
$7.77
Market Capitalization
$1.3B
Today's Volume
$1.4M
52 Week High
$19.09
52 Week Low
$7.39
Revenue TTM
$95.1M
EBITDA
$-97.2M
Earnings Per Share (EPS)
$-1.09
Profit Margin
-111.64%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-99.52%

How to invest in Avadel Pharmaceuticals-adr Stock (AVDL) from India?

It is very easy for Indian residents to invest directly in Avadel Pharmaceuticals-adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avadel Pharmaceuticals-adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avadel Pharmaceuticals-adr or AVDL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avadel Pharmaceuticals-adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avadel Pharmaceuticals-adr shares which would translate to 0.110 fractional shares of Avadel Pharmaceuticals-adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Avadel Pharmaceuticals-adr, in just a few clicks!

Returns in Avadel Pharmaceuticals-adr for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Avadel Pharmaceuticals-adr investment value today

Current value as on today

₹60,460

Returns

₹39,540

(-39.54%)

Returns from Avadel Pharmaceuticals-adr Stock

₹43,239 (-43.24%)

Dollar Returns

₹3,700 (+3.7%)

Indian investors sentiment towards Avadel Pharmaceuticals-adr

16%

Period: Oct 26, 2024 to Jan 24, 2025. Change in 30 Days versus previous period

Search volume for Avadel Pharmaceuticals-adr on INDmoney from India has grown in the last 30 days as on Jan 25, 2025. 16% more investors are searching Avadel Pharmaceuticals-adr in the last 30 days versus the previous period.

Global Institutional Holdings in Avadel Pharmaceuticals-adr

  • HHG PLC

    13.83%

  • Gendell Jeffrey L

    6.02%

  • BlackRock Inc

    5.46%

  • Polar Capital Holdings PLC

    5.02%

  • Vanguard Group Inc

    4.01%

  • BRAIDWELL LP

    3.52%

Analyst Recommendation on Avadel Pharmaceuticals-adr

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Avadel Pharmaceuticals-adr(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
14
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Avadel Pharmaceuticals-adr

What analysts predicted

Upside of 214.65%

Target:

$24.70

Current:

$7.85

Insights on Avadel Pharmaceuticals-adr

  • Price Movement

    In the last 1 month, AVDL stock has moved down by -23.3%
  • AVDL vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 90.1% return, outperforming this stock by 132.9%
  • AVDL vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 173.0% return, outperforming this stock by 136.5%
  • Price to Sales

    ForAVDL every $1 of sales, investors are willing to pay $7.6, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.9 for every $1 of sales.

Avadel Pharmaceuticals-adr Technicals Summary

Sell

Neutral

Buy

Avadel Pharmaceuticals-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Avadel Pharmaceuticals-adr Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avadel Pharmaceuticals-adr logo
-26.01%
-51.9%
-43.24%
38.45%
11.98%
Intra-cellular Therapies, Inc. logo
48.08%
62.87%
89.03%
166.81%
447.98%
Haleon Plc Spon Ads logo
-3.59%
2.62%
14.93%
26.72%
26.72%
Zoetis Inc. logo
1.87%
-7.27%
-11.96%
-11.18%
24.01%
Neurocrine Biosciences Inc. logo
6.98%
2.4%
4.63%
96.97%
50.77%
Viatris Inc. logo
-10.83%
-5.88%
-6.12%
-23.39%
-31.46%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avadel Pharmaceuticals-adr logo
NA
NA
0.07
-0.46
-1.0
-0.34
NA
0.98
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
-0.7
-0.1
-0.07
NA
10.8
Haleon Plc Spon Ads logo
28.0
28.0
1.65
0.36
0.07
0.04
0.02
1.82
Zoetis Inc. logo
31.32
31.32
2.61
5.88
0.47
0.15
0.01
11.59
Neurocrine Biosciences Inc. logo
39.03
39.03
0.34
6.6
0.16
0.12
NA
26.87
Viatris Inc. logo
224.4
NA
0.07
2.69
-0.04
0.02
0.04
16.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avadel Pharmaceuticals-adr logo
Buy
$1.3B
11.98%
NA
-111.64%
Intra-cellular Therapies, Inc. logo
Buy
$13.4B
447.98%
NA
-14.07%
Haleon Plc Spon Ads logo
Buy
$41.8B
26.72%
28.0
10.75%
Zoetis Inc. logo
Buy
$75.2B
24.01%
31.32
26.55%
Neurocrine Biosciences Inc. logo
Buy
$14.9B
50.77%
39.03
17.21%
Viatris Inc. logo
Hold
$13.5B
-31.46%
224.4
-5.87%

About Avadel Pharmaceuticals-adr

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Organization
Avadel Pharmaceuticals-adr
Employees
154
CEO
Mr. Gregory J. Divis Jr.
Industry
Health Technology

Management People of Avadel Pharmaceuticals-adr

NameTitle
Mr. Gregory J. Divis Jr.
CEO & Director
Mr. Thomas S. McHugh
Senior VP, Principal Financial and Accounting Officer & CFO
Mr. Jerad G. Seurer
General Counsel & Company Secretary
Mr. Gregory J. Davis
VP of Corporate and Business Development
Mr. Mark W. Elrod
Vice President of Sales
Ms. Angie Woods
Vice President of People & Culture
Dr. Jordan S. Dubow M.D.
Consultant
Dr. Jason M. Vaughn
Senior Vice President of Technical Operations
Ms. Jennifer Gudeman PharmD
Senior Vice President of Medical & Clinical Affairs

Important FAQs about investing in Avadel Pharmaceuticals-adr (AVDL) from India :

What is Avadel Pharmaceuticals-adr share price today?

Avadel Pharmaceuticals-adr share price today stands at $7.85, Open: $7.90 ; Previous Close: $7.94 ; High: $7.98 ; Low: $7.77 ; 52 Week High: $19.09 ; 52 Week Low: $7.39. The stock opens at $7.90, after a previous close of $7.94. The stock reached a daily high of $7.98 and a low of $7.77, with a 52-week high of $19.09 and a 52-week low of $7.39.

Can Indians buy Avadel Pharmaceuticals-adr shares?

Yes, Indians can invest in the Avadel Pharmaceuticals-adr (AVDL) from India.

With INDmoney, you can buy Avadel Pharmaceuticals-adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avadel Pharmaceuticals-adr at zero transaction cost.

How can I buy Avadel Pharmaceuticals-adr shares from India?

It is very easy to buy Avadel Pharmaceuticals-adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avadel Pharmaceuticals-adr be purchased?

Yes, you can buy fractional shares of Avadel Pharmaceuticals-adr with INDmoney app.

What are the documents required to start investing in Avadel Pharmaceuticals-adr stocks?

To start investing in Avadel Pharmaceuticals-adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Avadel Pharmaceuticals-adr

Today’s highest price of Avadel Pharmaceuticals-adr (AVDL) is $7.98.

Today’s lowest price of Avadel Pharmaceuticals-adr (AVDL) is $7.77.

What is today's market capitalisation of Avadel Pharmaceuticals-adr

Today's market capitalisation of Avadel Pharmaceuticals-adr AVDL is 1.3B

What is the 52 Week High and Low Range of Avadel Pharmaceuticals-adr

  • 52 Week High

    $19.09

  • 52 Week Low

    $7.39

What are the historical returns of Avadel Pharmaceuticals-adr?

  • 1 Month Returns

    -26.01%

  • 3 Months Returns

    -51.9%

  • 1 Year Returns

    -43.24%

  • 5 Years Returns

    11.98%

Who is the Chief Executive Officer (CEO) of Avadel Pharmaceuticals-adr

Mr. Gregory J. Divis Jr. is the current Chief Executive Officer (CEO) of Avadel Pharmaceuticals-adr.